TRANSIL Membrane Affinity Kit

Measure Membrane Affinity – The Mechanistic Alternative to LogP

Rapid determination of compound–membrane interaction in a cell-free system. Use as a pre-screen for the TRANSIL High Sensitivity Binding Kit, a screening tool for membrane-driven ADME properties, or a general membrane permeability assay.

Key benefits:

• Direct measurement of membrane partitioning
• Cell-free membrane model
• Rapid equilibrium assay (minutes)
• Automation-ready 96-well format
• Ideal pre-test for the TRANSIL High Sensitivity Binding Kit
• Applicable in drug discovery, environmental science, and molecular biology

Lipophilicity is Not Membrane Interaction

Lipophilicity parameters such as logP or logD are widely used to estimate permeability and tissue distribution. However, these metrics measure partitioning between water and an organic solvent (typically octanol). Biological membranes are fundamentally different systems. They are structured phospholipid bilayers containing charged headgroups, hydrophobic cores, and heterogeneous lipid compositions. Molecules interact with these membranes through a combination of hydrophobic, electrostatic, and hydrogen-bond interactions that are not captured by simple solvent partitioning. As a result, compounds with similar lipophilicity can exhibit very different membrane affinities and permeability behavior. Direct measurement of membrane partitioning into phospholipid bilayers therefore provides a more mechanistic descriptor of how molecules interact with biological membranes than lipophilicity alone.

The TRANSIL Membrane Affinity Kit

The TRANSIL Membrane Affinity Kit directly measures how compounds interact with phospholipid membranes. Lipid bilayers immobilized on porous beads provide a well- defined membrane phase that mimics the fundamental structure of biological membranes. Test compounds rapidly partition between the aqueous phase and the membrane phase until equilibrium is reached. Quantifying the compound concentration in the aqueous phase allows calculation of the membrane affinity coefficient, a mechanistic descriptor of drug–membrane interaction that is directly relevant to permeability, tissue distribution, and intracellular binding.

How the Assay Works

Membrane affinity is quantified by measuring how compounds partition between the aqueous phase and immobilized phosphatidylcholine membranes. Following separation of the membrane beads, the remaining compound concentration in the supernatant is determined and used to calculate the membrane affinity coefficient.

The assay determines membrane affinity through the following equilibrium partitioning workflow:

1. Compound is added to wells containing increasing amounts of membrane- coated beads
2. Compound partitions between membrane and aqueous phase
3. Supernatant concentration is quantified
4. Membrane affinity is calculated from the equilibrium distribution

Applications

Membrane interaction strongly influences equilibrium-shift based plasma protein binding assays. The TRANSIL Membrane Affinity Kit provides a rapid pre-test to quantify membrane interaction and determine the recommended plasma dilution for the TRANSIL High Sensitivity Binding Kit, ensuring robust assay conditions and accurate plasma protein binding estimates

Membrane partitioning is a key determinant of many ADME properties, including permeability, tissue distribution, and intracellular binding. The TRANSIL Membrane Affinity Kit enables rapid experimental assessment of compound–membrane interaction early in drug discovery. While specialized TRANSIL kits use optimized membrane compositions to predict specific parameters such as brain tissue binding or intracellular binding, this assay provides a fast first approximation of membrane- driven ADME behavior.

Membrane permeability is an important determinant of the biological activity and environmental behavior of many chemicals. In environmental toxicology and molecular biology, permeability is often estimated indirectly from lipophilicity parameters such as logP. The TRANSIL Membrane Affinity Kit provides a direct experimental alternative by measuring partitioning into phospholipid membranes, enabling rapid assessment of membrane interaction and permeability potential for environmental chemicals, pollutants, pesticides, and biomolecules in a controlled cell-free system.

The TRANSIL technology platform has been extensively validated for the prediction of ADME properties that depend on membrane partitioning. Numerous studies have demonstrated that membrane affinity measured with TRANSIL assays correlates with experimentally determined parameters such as plasma protein binding, intracellular binding, and brain tissue binding when appropriate membrane models are used. These validations form the scientific basis for the TRANSIL platform of membrane affinity assays.

The TRANSIL Membrane Affinity Kit uses a generic phospholipid membrane model that captures the fundamental interaction between compounds and lipid bilayers. This assay provides a rapid experimental estimate of membrane interaction and is therefore particularly useful for early screening applications and assay development workflows. For quantitative prediction of specific pharmacokinetic parameters, specialized TRANSIL kits use optimized membrane compositions that mimic the lipid environments of individual tissues.

The TRANSIL platform has been validated for multiple applications, including:

• Plasma protein binding prediction
• Intracellular binding estimation
• Brain tissue binding prediction
• Correction of metabolic clearance bias
• Intestinal Absorption

Each of these applications is implemented in dedicated TRANSIL assay kits optimized for the respective biological membrane system.

The TRANSIL Membrane Affinity Kit provides a rapid entry point into this technology by enabling fast experimental determination of compound–membrane interaction before applying specialized TRANSIL assays.